(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

WASKYRA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

WASKYRA

ST13

US500000079430823

Class

5, 42, 44

Filing

79430823

Registration

8182426

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

19

Latest update

06/24/2026

Trademark type

Word

Nice classes

5, 42, 44

Filing date

06/03/2025

Registration date

03/24/2026

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/24/2026

Last transaction

06/24/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

IT

Examiner

OSGOOD, KRYSTINA E

Law office

N30

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

F. E. (pessoa física)

Representatives

Michael J. Leonard Fox Rothschild LLP

Technical classification

Nice Classes

Class 5Class 42Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for gene therapy for the treatment of Wiskott-Aldrich syndrome; medicineEtuvetidigene autotemcel; pharmaceutical preparations for treating Wiskott-Aldrich syndrome

Class 42

Biological researchclinical research in the field of gene therapy and medical research; medical research laboratory services; research and development of vaccines and medicines; scientific research services in the preparation of biological samples for testing and analysis in research laboratories; genetic scientific research; scientific research and development; pharmaceutical drug development services; providing information on clinical studies via an interactive website; medical and scientific researchconducting clinical trials for others; DNA screening for scientific research purposes; design and development of computer hardware and software; research and development of new products for others; conducting technical scientific feasibility project studies; rental of computer software for collectinganalysing and organizing data in the field of medical research and treatment of genetic diseases; computer programming; conversion of computer programs and dataother than physical conversion; recovery of computer data; quality control for others; material testing; engineeringsurveying; conversion of data or documents from physical to electronic media; bacteriological research; hosting of communication computer platforms on the internet; programming of software for Internet platforms; pharmaceutical products development; scientific research services; scientific laboratory services; structural and functional analysis of genomes; development of pharmaceutical preparations and medicines; scientific research consultancy in relation to assessmentsestimatesresearches in science and technology rendered by engineers; providing information in the nature of evaluations and estimations in the field of medical research; industrial research and biological analysis in the field of health; providing of imaging and physiology platformsproviding temporary use of online non-downloadable software for analysing medical imaging; research and development of pharmaceuticals and veterinary and hygiene preparations for others; product development and testing of pharmaceuticals in the validation of biological testscellular testsgenetic tests and immunological tests; gene therapy research and scientific research

Class 44

Medical services; medical screening; medical assistance; medical counselling; providing news and information in the field of medicine; performing diagnosis of diseases; medical advisory services relating to degenerative diseases; medical surgical diagnostic services; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical diagnostic services; human hygiene and beauty care; health counselling; hospital services; nursing home services; pharmacy adviceprescription management and reviews; medical imaging services; human tissue bank services; conducting of medical examinations; medical consultations; medical and health care services relating to DNAgenetics and genetic testing; telemedicine services; stem cell therapy services; preparation and dispensing of medications; providing of medical information in the pharmaceutical field; medicalalternative medicinal and pharmaceutical consultancy

Publications

History of USPTO decisions and trademark events.

19 publications found

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

06/24/2026

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

03/24/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

03/24/2026

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/03/2026

PUBO

PUBLISHED FOR OPPOSITION

02/03/2026

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/28/2026

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/12/2026

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/24/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/24/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

12/24/2025

RFNT

REFUSAL PROCESSED BY IB

12/18/2025

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

12/04/2025

RFRR

REFUSAL PROCESSED BY MPU

12/04/2025

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

10/22/2025

CNRT

NON-FINAL ACTION WRITTEN

10/21/2025

DOCK

ASSIGNED TO EXAMINER

10/21/2025

MAFR

APPLICATION FILING RECEIPT MAILED

08/25/2025

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

08/25/2025

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

08/21/2025

Continuous trademark protection

Get notified about every new filing that threatens WASKYRA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.